Publications by authors named "Irene Fermont"

Claim this Profile
[
[The revolution of AI in drug development].
Philippe Moingeon, Christiane Garbay, Muriel Dahan, Irène Fermont, Ali Benmakhlouf

Med Sci (Paris)· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Communicating for the Safe Use of Medicines: Progress and Directions for the 2020s Promoted by the Special Interest Group of the International Society of Pharmacovigilance.
Priya Bahri, Geoffrey Bowring, Brian D Edwards, Christopher Anton, Jeffrey K Aronson, Irene Fermont

Drug Saf· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk communication on vaccines during the COVID19 pandemic: is there room for small size or private initiatives? An Israeli experience.
Irene R Fermont, Ayalah Livneh, Michel Benhamou

Ther Adv Drug Saf· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacovigilance strategy: opportunities for cross-national learning.
Irene Fermont

Isr J Health Policy Res· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The ISoP CommSIG for Improving Medicinal Product Risk Communication: A New Special Interest Group of the International Society of Pharmacovigilance.
Priya Bahri, Alexander N Dodoo, Brian D Edwards, I Ralph Edwards, Irene Fermont

Drug Saf· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis